Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

On July 25, the radiation oncology department at Tübingen University Hospital introduced its new Elekta Unity MR-linac, a groundbreaking cancer treatment system that integrates two critical but distinct technologies in a single platform: a state-of-the-art, high field wide bore 1.5 Tesla MR imaging system and a next-generation linear accelerator.

27 Jul 2018

Researchers shed light on risks presented by residual disease for younger breast cancer patients

A new study from the Stanford Cancer Institute finds that young women who are treated with chemotherapy for breast cancer but have residual tumor in either the breast or lymph nodes have higher chances of recurrence compared to those with no evidence of any residual invasive tumor (pathologic complete response).

23 Jul 2018

Clinical trial tests one-time, high-dose radiation treatment for early-stage breast cancer

For 81-year-old Marilyn Gibson, it was a no-brainer: Would she be interested in having a single dose of radiation to treat her breast cancer instead of the standard, multiple-dose treatment delivered over several weeks?

23 Jul 2018

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.

23 Jul 2018

Study finds wide variations in follow-up imaging for women with non-metastatic breast cancer

Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UC San Francisco.

13 Jul 2018

AVO and RaySearch enter into collaboration agreement to support the LIGHT system

The UK based developer of next generation proton therapy technology, Advanced Oncotherapy plc, has selected RayStation as its treatment planning system for the first LIGHT system at the proton therapy facility under construction at Harley Street in central London.

From RaySearch Laboratories AB 6 Jul 2018

RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy

RaySearch and Eckert & Ziegler BEBIG, a leading European supplier of brachytherapy products, have signed a partnership agreement. Both the RayStation treatment planning system and the RayCare oncology information system will be integrated with the Eckert & Ziegler BEBIG brachytherapy systems.

From RaySearch Laboratories AB 4 Jul 2018

Rabin Medical Center in Israel selects RayStation for radiation therapy treatment planning

Rabin Medical Center has selected RayStation for radiation therapy treatment planning at its Davidoff Cancer Center, located in Petah Tikva, Israel. This is the first order from a clinic in Israel, and the installation will include licenses for 3DCRT, IMRT, VMAT and adaptive therapy.

From RaySearch Laboratories AB 3 Jul 2018

Artificial ovaries could soon be a reality

Ovaries are female reproductive organs that are responsible for the production of ova or eggs. These are necessary for normal fertilization and development of the fetus. Fertility of a woman can be jeopardized when the ovaries do not function normally. Danish researchers have now successfully engineered artificial ovaries that could help millions of women with infertility related to ovarian disease and cancer therapy.

2 Jul 2018

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the treatment protocol for an invasive type of breast cancer that accounts for one-fifth of all breast cancer patients.

30 Jun 2018

New guidelines on how to diagnose, treat endocrine disorders in childhood cancer survivors

The Endocrine Society today issued a Clinical Practice Guideline advising healthcare providers on how to diagnose and treat the endocrine disorders that affect a significant portion of childhood cancer survivors in the United States today.

30 Jun 2018

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator on the first trial and as local PI on three other trials.

30 Jun 2018

Genetic biomarker can help predict survival outcomes in patients with certain gliomas

A DNA-level biomarker (MGMT promoter methylation) can be used to help predict survival outcomes in patients with high-risk, low-grade gliomas, according to a new study conducted through the NRG Oncology/RTOG collaborative clinical trials group and led by scientists at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

28 Jun 2018

DNA methylation predicts survival outcome in patients with glioma

A new study has shown that survival rates among patients with glioma double if the tumor carries a methylated MGMT gene.

28 Jun 2018

New conference to establish roadmap for treatment-focused research on smell and taste disorders

The Monell Center, in partnership with the University of Florida Center for Smell and Taste and the Rocky Mountain Taste and Smell Center at the University of Colorado School of Medicine, will host an interdisciplinary two-day conference in November 2018 to establish a roadmap for treatment-focused research on smell and taste disorders.

27 Jun 2018

Combating cardiac complications caused by cancer treatment

Amie Goins has completed eight 5K runs in 2018. An impressive feat for a 46-year-old mother with a full-time job and two teenage sons to care for – downright astounding for a woman who was diagnosed with stage 2 breast cancer two days before Christmas last year. She's conquered months of treatment and difficult side effects while continuing to lace up.

26 Jun 2018

Radiation Therapy News and Research

Further Reading

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

Researchers shed light on risks presented by residual disease for younger breast cancer patients

Clinical trial tests one-time, high-dose radiation treatment for early-stage breast cancer

Pfizer announces FDA approval of biosimilar to Neupogen

Study finds wide variations in follow-up imaging for women with non-metastatic breast cancer

AVO and RaySearch enter into collaboration agreement to support the LIGHT system

RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy

Rabin Medical Center in Israel selects RayStation for radiation therapy treatment planning

Artificial ovaries could soon be a reality

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

New guidelines on how to diagnose, treat endocrine disorders in childhood cancer survivors

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Genetic biomarker can help predict survival outcomes in patients with certain gliomas

DNA methylation predicts survival outcome in patients with glioma

New conference to establish roadmap for treatment-focused research on smell and taste disorders

Combating cardiac complications caused by cancer treatment

RaySearch releases new RayStation 8A to expand support for TomoTherapy platform

Radiation therapy alone may be enough to treat older, sicker patients with anal cancers

Physicians test technique to preserve potency in men undergoing prostate cancer therapy

Breast cancer treated successfully with immune therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News